Cargando…
Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
Gastric cancer is a disease with high heterogeneity, and this heterogeneity may result in an uneven distribution of subclones with varied genetic properties at disease locations (spatial heterogeneity) or temporal changes in subclonal composition (temporal heterogeneity). We present the case of a 69...
Autores principales: | Zhang, Qi, Yu, Tao, Zhao, Zhicheng, Zhang, Shiyao, Huang, Qianpeng, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112548/ https://www.ncbi.nlm.nih.gov/pubmed/35578236 http://dx.doi.org/10.1186/s12957-022-02615-0 |
Ejemplares similares
-
Intraindividual Tumor Heterogeneity of Mismatch Repair Status in Metastatic Colorectal Cancer
por: Huang, Qianpeng, et al.
Publicado: (2023) -
Prognostic impact of tumor size on patients with metastatic colorectal cancer: a large SEER-based retrospective cohort study
por: Zhang, Qi, et al.
Publicado: (2023) -
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of (18)F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
por: Gong, Chengcheng, et al.
Publicado: (2022) -
Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer
por: Yu, Tao, et al.
Publicado: (2023) -
Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)